CoChat

Single-cell sequencing to multi-omics: technologies and applications

Open access

The DOI matches its Crossref record; 249 of the 251 references it cites were found in a registry or an index; 125 of the 175 sources its claims cite were checked for support.

Abstract

Cells, as the fundamental units of life, contain multidimensional spatiotemporal information. Single-cell RNA sequencing (scRNA-seq) is revolutionizing biomedical science by analyzing cellular state and intercellular heterogeneity. Undoubtedly, single-cell transcriptomics has emerged as one of the most vibrant research fields today. With the optimization and innovation of single-cell sequencing technologies, the intricate multidimensional details concealed within cells are gradually unveiled. The combination of scRNA-seq and other multi-omics is at the forefront of the single-cell field. This involves simultaneously measuring various omics data within individual cells, expanding our understanding across a broader spectrum of dimensions. Single-cell multi-omics precisely captures the multidimensional aspects of single-cell transcriptomes, immune repertoire, spatial information, temporal information, epitopes, and other omics in diverse spatiotemporal contexts. In addition to depicting the cell atlas of normal or diseased tissues, it also provides a cornerstone for studying cell differentiation and development patterns, disease heterogeneity, drug resistance mechanisms, and treatment strategies. Herein, we review traditional single-cell sequencing technologies and outline the latest advancements in single-cell multi-omics. We summarize the current status and challenges of applying single-cell multi-omics technologies to biological research and clinical applications. Finally, we discuss the limitations and challenges of single-cell multi-omics and potential strategies to address them.

Overview

CoChat Summary

TL;DR

This review summarizes single-cell sequencing and single-cell multi-omics technologies across temporal, spatial, genome, epigenome, proteome, immune repertoire, microbiome, and metabolome dimensions, and their biological and clinical applications. It also outlines current challenges, including high cost, strict sample requirements, computational integration, missing or mismatched information, and doublets.

Key findings

  • Single-cell multi-omics extends scRNA-seq by simultaneously measuring multiple modalities in the same cell, with the review cataloging technologies for time (metabolic RNA labeling, fluorescent timers, CRISPR/Cas9 lineage tracing), space (ISH/ISS, ROI selection, spatial barcoding), genome, epigenome, protein/epitope, immune repertoire, microbiome, and metabolome.
  • Reported cell/feature numbers include scSLAM-seq at 110 cells, scNT-seq at ∼55,000 cells, Well-TEMP-seq at 16,000 cells, TrackerSci at ∼800,000 cells, Zmen-seq at 8,976 cells, microSPLiT detecting subpopulations down to 0.142%, Microbe-seq with most single-amplified genomes over 95% purity, and mass spectrometry-based single-cell proteomics at about 1,500–2,500 proteins.
  • Applications span cell atlas construction, developmental biology, pathway identification, and novel target discovery, as well as clinical areas such as tumor immunology, host-microbe interactions, infectious diseases, cardiovascular disease, and neurological/brain disease. For example, scTrio-seq was applied to 25 cancer cells and identified two distinct subsets, and an integrated human single-cell eQTL database comprises ∼16 million SNPs and ∼0.69 million sceQTLs.
  • The review highlights that single-cell multi-omics can reveal cell states and targets not captured by transcriptomics alone, but also notes persistent challenges in cost, sample quality, data integration, sequencing depth, immune repertoire chain matching, and doublet removal.

Methods

  • Narrative review; no original experiments or new primary data are reported. It synthesizes published single-cell sequencing and single-cell multi-omics technologies and their biological/clinical applications.
  • Tables summarize time-resolved single-cell technologies (e.g., scSLAM-seq, NASC-seq, Sci-fate, scNT-seq, Well-TEMP-seq, scEU-seq, TrackerSci, Zmen-seq, CARLIN) and spatial transcriptomics/multi-omics technologies (e.g., smFISH, seqFISH+, MERFISH, STARmap PLUS, Geo-seq, DSP, 10× Visium, Slide-seq, Stereo-seq, DBiT-seq, spatial CITE-seq, Slide-tags) with resolution, data type, sample type, and genes/transcripts detected.
  • The review also discusses computational analysis tools and workflows, including Seurat, Scanpy, Monocle, RNA velocity, Palantir, CytoTRACE, SCENIC, CellChat, CellPhoneDB, and batch-correction methods such as CCA, MNN, and Harmony.

Limitations

  • The paper states that high cost and strict sample requirements discourage many researchers and restrict large-scale cohorts and clinical application; fresh tissue is generally preferred, freeze-thaw samples are usually recommended for snRNA-seq, and cell suspension quantity and viability affect data quality.
  • The paper states that robust computational methods for integrating multi-dimensional single-cell data are still needed, that inconsistencies can occur among omics measured simultaneously in the same cells, and that sequencing depth, missing or incorrectly matched TCR chains, and doublets can confound downstream analyses.
  • Evident from the text: as a narrative review, it does not perform a systematic search or quantitative synthesis and reports no primary validation data.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s40364-024-00643-4

Cites

249 of 249 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 (A) Conventional scRNA-seq technologies. (B) Overview of the single-cell multi-omics scheme
Fig. 1 (A) Conventional scRNA-seq technologies. (B) Overview of the single-cell multi-omics schemeCC BY · PubMed Central
Fig. 2 A brief method and principle of single-cell multi-omics technologies for (A) scTCR/BCR-seq, (B) ClickTag, (C) proteome, (D) microbiome, (E) metabolome, (F) epigenome
Fig. 2 A brief method and principle of single-cell multi-omics technologies for (A) scTCR/BCR-seq, (B) ClickTag, (C) proteome, (D) microbiome, (E) metabolome, (F) epigenomeCC BY · PubMed Central
Fig. 3 The principles of key technologies in the dimensions of (A) time and (B) space at the single-cell level
Fig. 3 The principles of key technologies in the dimensions of (A) time and (B) space at the single-cell levelCC BY · PubMed Central
Fig. 4 Applications of single-cell multi-omics in biological research and clinical practice
Fig. 4 Applications of single-cell multi-omics in biological research and clinical practiceCC BY · PubMed Central

Verification

Claims the paper makes

98 Valid · 9 Not valid · 33 Not checked · 20 Own results and interpretations

53 more claims · 32 with their cited sources checked

Create a free account to see all 160 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 65
  • Probably not a substantial claim. 50
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Citations

Cites

Research works printed but not linked: 1

  1. Galeano Nino JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, Futran N, Houlton J, Sather C, Sicinska E, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611:810–7. · DOI · Paper page

Cited by

See all 222

Metadata

Authors
Wu, X., Yang, X., Dai, Y., Zhao, Z., Zhu, J., Guo, H., & Yang, R.
Affiliations
  • Nanjing Drum Tower Hospital (CN)
  • Nanjing University (CN)
Corresponding author
  • Guo, Hongqian
  • Yang, Rong
Venue
Biomarker Research
Published
2024-09-27
Volume
12
Issue
1
Pages
110-110
ISSN
2050-7771 (ISSN-L)
OpenAlex
W4402912319
Cited by
222
References
251
Citations by year
2026: 115 · 2025: 102 · 2024: 5
FWCI
8.22
Type
journal article
Language
en
Open access
Licence
Locations
  • Biomarker Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Natural Science Foundation of China (81772710, 82172691)
  • Jiangsu Provincial Healthcare Commission Scientific Research Grant Top Project (M2020093)
  • Jiangsu Provincial Social Development Project (BE2023659)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
single-cell multi-omics, single-cell RNA sequencing, single-cell transcriptomics, immune repertoire, spatial transcriptomics, temporal transcriptomics, cell atlas, cell differentiation, disease heterogeneity, drug resistance, clinical application

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.